Global Prostate Cancer Vaccines Market Research Report 2023

Prostate Cancer Vaccines Market

The global Prostate Cancer Vaccines market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North American market for Prostate Cancer Vaccines is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Prostate Cancer Vaccines is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global manufacturers of Prostate Cancer Vaccines include Dendreon Corporation, Bavarian Nordic, Advantagene, OncBioMune Pharmaceuticals, Advaxis immunotherapies, SOTIO, Cleveland BioLabs Inc., Curevac AG and Mediolanum Farmaceutici, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Prostate Cancer Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prostate Cancer Vaccines.

The Prostate Cancer Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Prostate Cancer Vaccines market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Prostate Cancer Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

Scope of Prostate Cancer Vaccines Market Report

Core Chapters

1.1 Product Overview and Scope of Prostate Cancer Vaccines

1.2 Prostate Cancer Vaccines Segment by Type

1.2.1 Global Prostate Cancer Vaccines Market Value Comparison by Type (2023-2029)

1.2.2 Tablet

1.2.3 Injection

1.3 Prostate Cancer Vaccines Segment by Application

1.3.1 Global Prostate Cancer Vaccines Market Value by Application: (2023-2029)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 Global Prostate Cancer Vaccines Market Size Estimates and Forecasts

1.4.1 Global Prostate Cancer Vaccines Revenue 2018-2029

1.4.2 Global Prostate Cancer Vaccines Sales 2018-2029

1.4.3 Global Prostate Cancer Vaccines Market Average Price (2018-2029)

1.5 Assumptions and Limitations

2.1 Global Prostate Cancer Vaccines Sales Market Share by Manufacturers (2018-2023)

2.2 Global Prostate Cancer Vaccines Revenue Market Share by Manufacturers (2018-2023)

2.3 Global Prostate Cancer Vaccines Average Price by Manufacturers (2018-2023)

2.4 Global Prostate Cancer Vaccines Industry Ranking 2021 VS 2022 VS 2023

2.5 Global Key Manufacturers of Prostate Cancer Vaccines, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Prostate Cancer Vaccines, Product Type & Application

2.7 Prostate Cancer Vaccines Market Competitive Situation and Trends

2.7.1 Prostate Cancer Vaccines Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Prostate Cancer Vaccines Players Market Share by Revenue

2.7.3 Global Prostate Cancer Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3.1 Global Prostate Cancer Vaccines Market Size by Region: 2018 Versus 2022 Versus 2029

3.2 Global Prostate Cancer Vaccines Global Prostate Cancer Vaccines Sales by Region: 2018-2029

3.2.1 Global Prostate Cancer Vaccines Sales by Region: 2018-2023

3.2.2 Global Prostate Cancer Vaccines Sales by Region: 2024-2029

3.3 Global Prostate Cancer Vaccines Global Prostate Cancer Vaccines Revenue by Region: 2018-2029

3.3.1 Global Prostate Cancer Vaccines Revenue by Region: 2018-2023

3.3.2 Global Prostate Cancer Vaccines Revenue by Region: 2024-2029

3.4 North America Prostate Cancer Vaccines Market Facts & Figures by Country

3.4.1 North America Prostate Cancer Vaccines Market Size by Country: 2018 VS 2022 VS 2029

3.4.2 North America Prostate Cancer Vaccines Sales by Country (2018-2029)

3.4.3 North America Prostate Cancer Vaccines Revenue by Country (2018-2029)

3.4.4 United States

3.4.5 Canada

3.5 Europe Prostate Cancer Vaccines Market Facts & Figures by Country

3.5.1 Europe Prostate Cancer Vaccines Market Size by Country: 2018 VS 2022 VS 2029

3.5.2 Europe Prostate Cancer Vaccines Sales by Country (2018-2029)

3.5.3 Europe Prostate Cancer Vaccines Revenue by Country (2018-2029)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Prostate Cancer Vaccines Market Facts & Figures by Country

3.6.1 Asia Pacific Prostate Cancer Vaccines Market Size by Country: 2018 VS 2022 VS 2029

3.6.2 Asia Pacific Prostate Cancer Vaccines Sales by Country (2018-2029)

3.6.3 Asia Pacific Prostate Cancer Vaccines Revenue by Country (2018-2029)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Prostate Cancer Vaccines Market Facts & Figures by Country

3.7.1 Latin America Prostate Cancer Vaccines Market Size by Country: 2018 VS 2022 VS 2029

3.7.2 Latin America Prostate Cancer Vaccines Sales by Country (2018-2029)

3.7.3 Latin America Prostate Cancer Vaccines Revenue by Country (2018-2029)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Prostate Cancer Vaccines Market Facts & Figures by Country

3.8.1 Middle East and Africa Prostate Cancer Vaccines Market Size by Country: 2018 VS 2022 VS 2029

3.8.2 Middle East and Africa Prostate Cancer Vaccines Sales by Country (2018-2029)

3.8.3 Middle East and Africa Prostate Cancer Vaccines Revenue by Country (2018-2029)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4.1 Global Prostate Cancer Vaccines Sales by Type (2018-2029)

4.1.1 Global Prostate Cancer Vaccines Sales by Type (2018-2023)

4.1.2 Global Prostate Cancer Vaccines Sales by Type (2024-2029)

4.1.3 Global Prostate Cancer Vaccines Sales Market Share by Type (2018-2029)

4.2 Global Prostate Cancer Vaccines Revenue by Type (2018-2029)

4.2.1 Global Prostate Cancer Vaccines Revenue by Type (2018-2023)

4.2.2 Global Prostate Cancer Vaccines Revenue by Type (2024-2029)

4.2.3 Global Prostate Cancer Vaccines Revenue Market Share by Type (2018-2029)

4.3 Global Prostate Cancer Vaccines Price by Type (2018-2029)

5.1 Global Prostate Cancer Vaccines Sales by Application (2018-2029)

5.1.1 Global Prostate Cancer Vaccines Sales by Application (2018-2023)

5.1.2 Global Prostate Cancer Vaccines Sales by Application (2024-2029)

5.1.3 Global Prostate Cancer Vaccines Sales Market Share by Application (2018-2029)

5.2 Global Prostate Cancer Vaccines Revenue by Application (2018-2029)

5.2.1 Global Prostate Cancer Vaccines Revenue by Application (2018-2023)

5.2.2 Global Prostate Cancer Vaccines Revenue by Application (2024-2029)

5.2.3 Global Prostate Cancer Vaccines Revenue Market Share by Application (2018-2029)

5.3 Global Prostate Cancer Vaccines Price by Application (2018-2029)

6.1 Dendreon Corporation

6.1.1 Dendreon Corporation Corporation Information

6.1.2 Dendreon Corporation Description and Business Overview

6.1.3 Dendreon Corporation Prostate Cancer Vaccines Sales, Revenue and Gross Margin (2018-2023)

6.1.4 Dendreon Corporation Prostate Cancer Vaccines Product Portfolio

6.1.5 Dendreon Corporation Recent Developments/Updates

6.2 Bavarian Nordic

6.2.1 Bavarian Nordic Corporation Information

6.2.2 Bavarian Nordic Description and Business Overview

6.2.3 Bavarian Nordic Prostate Cancer Vaccines Sales, Revenue and Gross Margin (2018-2023)

6.2.4 Bavarian Nordic Prostate Cancer Vaccines Product Portfolio

6.2.5 Bavarian Nordic Recent Developments/Updates

6.3 Advantagene

6.3.1 Advantagene Corporation Information

6.3.2 Advantagene Description and Business Overview

6.3.3 Advantagene Prostate Cancer Vaccines Sales, Revenue and Gross Margin (2018-2023)

6.3.4 Advantagene Prostate Cancer Vaccines Product Portfolio

6.3.5 Advantagene Recent Developments/Updates

6.4 OncBioMune Pharmaceuticals

6.4.1 OncBioMune Pharmaceuticals Corporation Information

6.4.2 OncBioMune Pharmaceuticals Description and Business Overview

6.4.3 OncBioMune Pharmaceuticals Prostate Cancer Vaccines Sales, Revenue and Gross Margin (2018-2023)

6.4.4 OncBioMune Pharmaceuticals Prostate Cancer Vaccines Product Portfolio

6.4.5 OncBioMune Pharmaceuticals Recent Developments/Updates

6.5 Advaxis immunotherapies

6.5.1 Advaxis immunotherapies Corporation Information

6.5.2 Advaxis immunotherapies Description and Business Overview

6.5.3 Advaxis immunotherapies Prostate Cancer Vaccines Sales, Revenue and Gross Margin (2018-2023)

6.5.4 Advaxis immunotherapies Prostate Cancer Vaccines Product Portfolio

6.5.5 Advaxis immunotherapies Recent Developments/Updates

6.6 SOTIO

6.6.1 SOTIO Corporation Information

6.6.2 SOTIO Description and Business Overview

6.6.3 SOTIO Prostate Cancer Vaccines Sales, Revenue and Gross Margin (2018-2023)

6.6.4 SOTIO Prostate Cancer Vaccines Product Portfolio

6.6.5 SOTIO Recent Developments/Updates

6.7 Cleveland BioLabs Inc.

6.6.1 Cleveland BioLabs Inc. Corporation Information

6.6.2 Cleveland BioLabs Inc. Description and Business Overview

6.6.3 Cleveland BioLabs Inc. Prostate Cancer Vaccines Sales, Revenue and Gross Margin (2018-2023)

6.4.4 Cleveland BioLabs Inc. Prostate Cancer Vaccines Product Portfolio

6.7.5 Cleveland BioLabs Inc. Recent Developments/Updates

6.8 Curevac AG

6.8.1 Curevac AG Corporation Information

6.8.2 Curevac AG Description and Business Overview

6.8.3 Curevac AG Prostate Cancer Vaccines Sales, Revenue and Gross Margin (2018-2023)

6.8.4 Curevac AG Prostate Cancer Vaccines Product Portfolio

6.8.5 Curevac AG Recent Developments/Updates

6.9 Mediolanum Farmaceutici

6.9.1 Mediolanum Farmaceutici Corporation Information

6.9.2 Mediolanum Farmaceutici Description and Business Overview

6.9.3 Mediolanum Farmaceutici Prostate Cancer Vaccines Sales, Revenue and Gross Margin (2018-2023)

6.9.4 Mediolanum Farmaceutici Prostate Cancer Vaccines Product Portfolio

6.9.5 Mediolanum Farmaceutici Recent Developments/Updates

6.10 Pfizer Inc.

6.10.1 Pfizer Inc. Corporation Information

6.10.2 Pfizer Inc. Description and Business Overview

6.10.3 Pfizer Inc. Prostate Cancer Vaccines Sales, Revenue and Gross Margin (2018-2023)

6.10.4 Pfizer Inc. Prostate Cancer Vaccines Product Portfolio

6.10.5 Pfizer Inc. Recent Developments/Updates

6.11 Vaccitech

6.11.1 Vaccitech Corporation Information

6.11.2 Vaccitech Prostate Cancer Vaccines Description and Business Overview

6.11.3 Vaccitech Prostate Cancer Vaccines Sales, Revenue and Gross Margin (2018-2023)

6.11.4 Vaccitech Prostate Cancer Vaccines Product Portfolio

6.11.5 Vaccitech Recent Developments/Updates

6.12 Sensei Biotherapeutics

6.12.1 Sensei Biotherapeutics Corporation Information

6.12.2 Sensei Biotherapeutics Prostate Cancer Vaccines Description and Business Overview

6.12.3 Sensei Biotherapeutics Prostate Cancer Vaccines Sales, Revenue and Gross Margin (2018-2023)

6.12.4 Sensei Biotherapeutics Prostate Cancer Vaccines Product Portfolio

6.12.5 Sensei Biotherapeutics Recent Developments/Updates

6.13 Medigene AG

6.13.1 Medigene AG Corporation Information

6.13.2 Medigene AG Prostate Cancer Vaccines Description and Business Overview

6.13.3 Medigene AG Prostate Cancer Vaccines Sales, Revenue and Gross Margin (2018-2023)

6.13.4 Medigene AG Prostate Cancer Vaccines Product Portfolio

6.13.5 Medigene AG Recent Developments/Updates

6.14 Ultimovacs

6.14.1 Ultimovacs Corporation Information

6.14.2 Ultimovacs Prostate Cancer Vaccines Description and Business Overview

6.14.3 Ultimovacs Prostate Cancer Vaccines Sales, Revenue and Gross Margin (2018-2023)

6.14.4 Ultimovacs Prostate Cancer Vaccines Product Portfolio

6.14.5 Ultimovacs Recent Developments/Updates

6.15 Oncovir Inc.

6.15.1 Oncovir Inc. Corporation Information

6.15.2 Oncovir Inc. Prostate Cancer Vaccines Description and Business Overview

6.15.3 Oncovir Inc. Prostate Cancer Vaccines Sales, Revenue and Gross Margin (2018-2023)

6.15.4 Oncovir Inc. Prostate Cancer Vaccines Product Portfolio

6.15.5 Oncovir Inc. Recent Developments/Updates

6.16 UbiVac

6.16.1 UbiVac Corporation Information

6.16.2 UbiVac Prostate Cancer Vaccines Description and Business Overview

6.16.3 UbiVac Prostate Cancer Vaccines Sales, Revenue and Gross Margin (2018-2023)

6.16.4 UbiVac Prostate Cancer Vaccines Product Portfolio

6.16.5 UbiVac Recent Developments/Updates

6.17 Momotaro-Gene Inc.

6.17.1 Momotaro-Gene Inc. Corporation Information

6.17.2 Momotaro-Gene Inc. Prostate Cancer Vaccines Description and Business Overview

6.17.3 Momotaro-Gene Inc. Prostate Cancer Vaccines Sales, Revenue and Gross Margin (2018-2023)

6.17.4 Momotaro-Gene Inc. Prostate Cancer Vaccines Product Portfolio

6.17.5 Momotaro-Gene Inc. Recent Developments/Updates

6.18 Vaccibody AS

6.18.1 Vaccibody AS Corporation Information

6.18.2 Vaccibody AS Prostate Cancer Vaccines Description and Business Overview

6.18.3 Vaccibody AS Prostate Cancer Vaccines Sales, Revenue and Gross Margin (2018-2023)

6.18.4 Vaccibody AS Prostate Cancer Vaccines Product Portfolio

6.18.5 Vaccibody AS Recent Developments/Updates

6.19 AlphaVax Inc.

6.19.1 AlphaVax Inc. Corporation Information

6.19.2 AlphaVax Inc. Prostate Cancer Vaccines Description and Business Overview

6.19.3 AlphaVax Inc. Prostate Cancer Vaccines Sales, Revenue and Gross Margin (2018-2023)

6.19.4 AlphaVax Inc. Prostate Cancer Vaccines Product Portfolio

6.19.5 AlphaVax Inc. Recent Developments/Updates

7.1 Prostate Cancer Vaccines Industry Chain Analysis

7.2 Prostate Cancer Vaccines Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Prostate Cancer Vaccines Production Mode & Process

7.4 Prostate Cancer Vaccines Sales and Marketing

7.4.1 Prostate Cancer Vaccines Sales Channels

7.4.2 Prostate Cancer Vaccines Distributors

7.5 Prostate Cancer Vaccines Customers

8.1 Prostate Cancer Vaccines Industry Trends

8.2 Prostate Cancer Vaccines Market Drivers

8.3 Prostate Cancer Vaccines Market Challenges

8.4 Prostate Cancer Vaccines Market Restraints

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

List of Tables

    Table 1. Global Prostate Cancer Vaccines Market Value Comparison by Type (2023-2029) & (US$ Million)

    Table 2. Global Prostate Cancer Vaccines Market Value Comparison by Application (2023-2029) & (US$ Million)

    Table 3. Global Prostate Cancer Vaccines Market Competitive Situation by Manufacturers in 2022

    Table 4. Global Prostate Cancer Vaccines Sales (K Units) of Key Manufacturers (2018-2023)

    Table 5. Global Prostate Cancer Vaccines Sales Market Share by Manufacturers (2018-2023)

    Table 6. Global Prostate Cancer Vaccines Revenue (US$ Million) by Manufacturers (2018-2023)

    Table 7. Global Prostate Cancer Vaccines Revenue Share by Manufacturers (2018-2023)

    Table 8. Global Market Prostate Cancer Vaccines Average Price (US$/Unit) of Key Manufacturers (2018-2023)

    Table 9. Global Key Players of Prostate Cancer Vaccines, Industry Ranking, 2021 VS 2022 VS 2023

    Table 10. Global Key Manufacturers of Prostate Cancer Vaccines, Manufacturing Sites & Headquarters

    Table 11. Global Key Manufacturers of Prostate Cancer Vaccines, Product Type & Application

    Table 12. Global Key Manufacturers of Prostate Cancer Vaccines, Date of Enter into This Industry

    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

    Table 14. Global Prostate Cancer Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Vaccines as of 2022)

    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

    Table 16. Global Prostate Cancer Vaccines Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 17. Global Prostate Cancer Vaccines Sales by Region (2018-2023) & (K Units)

    Table 18. Global Prostate Cancer Vaccines Sales Market Share by Region (2018-2023)

    Table 19. Global Prostate Cancer Vaccines Sales by Region (2024-2029) & (K Units)

    Table 20. Global Prostate Cancer Vaccines Sales Market Share by Region (2024-2029)

    Table 21. Global Prostate Cancer Vaccines Revenue by Region (2018-2023) & (US$ Million)

    Table 22. Global Prostate Cancer Vaccines Revenue Market Share by Region (2018-2023)

    Table 23. Global Prostate Cancer Vaccines Revenue by Region (2024-2029) & (US$ Million)

    Table 24. Global Prostate Cancer Vaccines Revenue Market Share by Region (2024-2029)

    Table 25. North America Prostate Cancer Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 26. North America Prostate Cancer Vaccines Sales by Country (2018-2023) & (K Units)

    Table 27. North America Prostate Cancer Vaccines Sales by Country (2024-2029) & (K Units)

    Table 28. North America Prostate Cancer Vaccines Revenue by Country (2018-2023) & (US$ Million)

    Table 29. North America Prostate Cancer Vaccines Revenue by Country (2024-2029) & (US$ Million)

    Table 30. Europe Prostate Cancer Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 31. Europe Prostate Cancer Vaccines Sales by Country (2018-2023) & (K Units)

    Table 32. Europe Prostate Cancer Vaccines Sales by Country (2024-2029) & (K Units)

    Table 33. Europe Prostate Cancer Vaccines Revenue by Country (2018-2023) & (US$ Million)

    Table 34. Europe Prostate Cancer Vaccines Revenue by Country (2024-2029) & (US$ Million)

    Table 35. Asia Pacific Prostate Cancer Vaccines Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)

    Table 36. Asia Pacific Prostate Cancer Vaccines Sales by Region (2018-2023) & (K Units)

    Table 37. Asia Pacific Prostate Cancer Vaccines Sales by Region (2024-2029) & (K Units)

    Table 38. Asia Pacific Prostate Cancer Vaccines Revenue by Region (2018-2023) & (US$ Million)

    Table 39. Asia Pacific Prostate Cancer Vaccines Revenue by Region (2024-2029) & (US$ Million)

    Table 40. Latin America Prostate Cancer Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 41. Latin America Prostate Cancer Vaccines Sales by Country (2018-2023) & (K Units)

    Table 42. Latin America Prostate Cancer Vaccines Sales by Country (2024-2029) & (K Units)

    Table 43. Latin America Prostate Cancer Vaccines Revenue by Country (2018-2023) & (US$ Million)

    Table 44. Latin America Prostate Cancer Vaccines Revenue by Country (2024-2029) & (US$ Million)

    Table 45. Middle East & Africa Prostate Cancer Vaccines Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 46. Middle East & Africa Prostate Cancer Vaccines Sales by Country (2018-2023) & (K Units)

    Table 47. Middle East & Africa Prostate Cancer Vaccines Sales by Country (2024-2029) & (K Units)

    Table 48. Middle East & Africa Prostate Cancer Vaccines Revenue by Country (2018-2023) & (US$ Million)

    Table 49. Middle East & Africa Prostate Cancer Vaccines Revenue by Country (2024-2029) & (US$ Million)

    Table 50. Global Prostate Cancer Vaccines Sales (K Units) by Type (2018-2023)

    Table 51. Global Prostate Cancer Vaccines Sales (K Units) by Type (2024-2029)

    Table 52. Global Prostate Cancer Vaccines Sales Market Share by Type (2018-2023)

    Table 53. Global Prostate Cancer Vaccines Sales Market Share by Type (2024-2029)

    Table 54. Global Prostate Cancer Vaccines Revenue (US$ Million) by Type (2018-2023)

    Table 55. Global Prostate Cancer Vaccines Revenue (US$ Million) by Type (2024-2029)

    Table 56. Global Prostate Cancer Vaccines Revenue Market Share by Type (2018-2023)

    Table 57. Global Prostate Cancer Vaccines Revenue Market Share by Type (2024-2029)

    Table 58. Global Prostate Cancer Vaccines Price (US$/Unit) by Type (2018-2023)

    Table 59. Global Prostate Cancer Vaccines Price (US$/Unit) by Type (2024-2029)

    Table 60. Global Prostate Cancer Vaccines Sales (K Units) by Application (2018-2023)

    Table 61. Global Prostate Cancer Vaccines Sales (K Units) by Application (2024-2029)

    Table 62. Global Prostate Cancer Vaccines Sales Market Share by Application (2018-2023)

    Table 63. Global Prostate Cancer Vaccines Sales Market Share by Application (2024-2029)

    Table 64. Global Prostate Cancer Vaccines Revenue (US$ Million) by Application (2018-2023)

    Table 65. Global Prostate Cancer Vaccines Revenue (US$ Million) by Application (2024-2029)

    Table 66. Global Prostate Cancer Vaccines Revenue Market Share by Application (2018-2023)

    Table 67. Global Prostate Cancer Vaccines Revenue Market Share by Application (2024-2029)

    Table 68. Global Prostate Cancer Vaccines Price (US$/Unit) by Application (2018-2023)

    Table 69. Global Prostate Cancer Vaccines Price (US$/Unit) by Application (2024-2029)

    Table 70. Dendreon Corporation Corporation Information

    Table 71. Dendreon Corporation Description and Business Overview

    Table 72. Dendreon Corporation Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 73. Dendreon Corporation Prostate Cancer Vaccines Product

    Table 74. Dendreon Corporation Recent Developments/Updates

    Table 75. Bavarian Nordic Corporation Information

    Table 76. Bavarian Nordic Description and Business Overview

    Table 77. Bavarian Nordic Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 78. Bavarian Nordic Prostate Cancer Vaccines Product

    Table 79. Bavarian Nordic Recent Developments/Updates

    Table 80. Advantagene Corporation Information

    Table 81. Advantagene Description and Business Overview

    Table 82. Advantagene Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 83. Advantagene Prostate Cancer Vaccines Product

    Table 84. Advantagene Recent Developments/Updates

    Table 85. OncBioMune Pharmaceuticals Corporation Information

    Table 86. OncBioMune Pharmaceuticals Description and Business Overview

    Table 87. OncBioMune Pharmaceuticals Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 88. OncBioMune Pharmaceuticals Prostate Cancer Vaccines Product

    Table 89. OncBioMune Pharmaceuticals Recent Developments/Updates

    Table 90. Advaxis immunotherapies Corporation Information

    Table 91. Advaxis immunotherapies Description and Business Overview

    Table 92. Advaxis immunotherapies Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 93. Advaxis immunotherapies Prostate Cancer Vaccines Product

    Table 94. Advaxis immunotherapies Recent Developments/Updates

    Table 95. SOTIO Corporation Information

    Table 96. SOTIO Description and Business Overview

    Table 97. SOTIO Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 98. SOTIO Prostate Cancer Vaccines Product

    Table 99. SOTIO Recent Developments/Updates

    Table 100. Cleveland BioLabs Inc. Corporation Information

    Table 101. Cleveland BioLabs Inc. Description and Business Overview

    Table 102. Cleveland BioLabs Inc. Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 103. Cleveland BioLabs Inc. Prostate Cancer Vaccines Product

    Table 104. Cleveland BioLabs Inc. Recent Developments/Updates

    Table 105. Curevac AG Corporation Information

    Table 106. Curevac AG Description and Business Overview

    Table 107. Curevac AG Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 108. Curevac AG Prostate Cancer Vaccines Product

    Table 109. Curevac AG Recent Developments/Updates

    Table 110. Mediolanum Farmaceutici Corporation Information

    Table 111. Mediolanum Farmaceutici Description and Business Overview

    Table 112. Mediolanum Farmaceutici Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 113. Mediolanum Farmaceutici Prostate Cancer Vaccines Product

    Table 114. Mediolanum Farmaceutici Recent Developments/Updates

    Table 115. Pfizer Inc. Corporation Information

    Table 116. Pfizer Inc. Description and Business Overview

    Table 117. Pfizer Inc. Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 118. Pfizer Inc. Prostate Cancer Vaccines Product

    Table 119. Pfizer Inc. Recent Developments/Updates

    Table 120. Vaccitech Corporation Information

    Table 121. Vaccitech Description and Business Overview

    Table 122. Vaccitech Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 123. Vaccitech Prostate Cancer Vaccines Product

    Table 124. Vaccitech Recent Developments/Updates

    Table 125. Sensei Biotherapeutics Corporation Information

    Table 126. Sensei Biotherapeutics Description and Business Overview

    Table 127. Sensei Biotherapeutics Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 128. Sensei Biotherapeutics Prostate Cancer Vaccines Product

    Table 129. Sensei Biotherapeutics Recent Developments/Updates

    Table 130. Medigene AG Corporation Information

    Table 131. Medigene AG Description and Business Overview

    Table 132. Medigene AG Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 133. Medigene AG Prostate Cancer Vaccines Product

    Table 134. Medigene AG Recent Developments/Updates

    Table 135. Ultimovacs Corporation Information

    Table 136. Ultimovacs Description and Business Overview

    Table 137. Ultimovacs Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 138. Ultimovacs Prostate Cancer Vaccines Product

    Table 139. Ultimovacs Recent Developments/Updates

    Table 140. Oncovir Inc. Corporation Information

    Table 141. Oncovir Inc. Description and Business Overview

    Table 142. Oncovir Inc. Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 143. Oncovir Inc. Prostate Cancer Vaccines Product

    Table 144. Oncovir Inc. Recent Developments/Updates

    Table 145. UbiVac Corporation Information

    Table 146. UbiVac Description and Business Overview

    Table 147. UbiVac Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 148. UbiVac Prostate Cancer Vaccines Product

    Table 149. UbiVac Recent Developments/Updates

    Table 150. Momotaro-Gene Inc. Corporation Information

    Table 151. Momotaro-Gene Inc. Description and Business Overview

    Table 152. Momotaro-Gene Inc. Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 153. Momotaro-Gene Inc. Prostate Cancer Vaccines Product

    Table 154. Momotaro-Gene Inc. Recent Developments/Updates

    Table 155. Vaccibody AS Corporation Information

    Table 156. Vaccibody AS Description and Business Overview

    Table 157. Vaccibody AS Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 158. Vaccibody AS Prostate Cancer Vaccines Product

    Table 159. Vaccibody AS Recent Developments/Updates

    Table 160. AlphaVax Inc. Corporation Information

    Table 161. AlphaVax Inc. Description and Business Overview

    Table 162. AlphaVax Inc. Prostate Cancer Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 163. AlphaVax Inc. Prostate Cancer Vaccines Product

    Table 164. AlphaVax Inc. Recent Developments/Updates

    Table 165. Key Raw Materials Lists

    Table 166. Raw Materials Key Suppliers Lists

    Table 167. Prostate Cancer Vaccines Distributors List

    Table 168. Prostate Cancer Vaccines Customers List

    Table 169. Prostate Cancer Vaccines Market Trends

    Table 170. Prostate Cancer Vaccines Market Drivers

    Table 171. Prostate Cancer Vaccines Market Challenges

    Table 172. Prostate Cancer Vaccines Market Restraints

    Table 173. Research Programs/Design for This Report

    Table 174. Key Data Information from Secondary Sources

    Table 175. Key Data Information from Primary Sources

List of Figures

    Figure 1. Product Picture of Prostate Cancer Vaccines

    Figure 2. Global Prostate Cancer Vaccines Market Value Comparison by Type (2023-2029) & (US$ Million)

    Figure 3. Global Prostate Cancer Vaccines Market Share by Type in 2022 & 2029

    Figure 4. Tablet Product Picture

    Figure 5. Injection Product Picture

    Figure 6. Global Prostate Cancer Vaccines Market Value Comparison by Application (2023-2029) & (US$ Million)

    Figure 7. Global Prostate Cancer Vaccines Market Share by Application in 2022 & 2029

    Figure 8. Hospital

    Figure 9. Clinic

    Figure 10. Others

    Figure 11. Global Prostate Cancer Vaccines Revenue, (US$ Million), 2018 VS 2022 VS 2029

    Figure 12. Global Prostate Cancer Vaccines Market Size (2018-2029) & (US$ Million)

    Figure 13. Global Prostate Cancer Vaccines Sales (2018-2029) & (K Units)

    Figure 14. Global Prostate Cancer Vaccines Average Price (US$/Unit) & (2018-2029)

    Figure 15. Prostate Cancer Vaccines Report Years Considered

    Figure 16. Prostate Cancer Vaccines Sales Share by Manufacturers in 2022

    Figure 17. Global Prostate Cancer Vaccines Revenue Share by Manufacturers in 2022

    Figure 18. The Global 5 and 10 Largest Prostate Cancer Vaccines Players: Market Share by Revenue in 2022

    Figure 19. Prostate Cancer Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022

    Figure 20. Global Prostate Cancer Vaccines Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Figure 21. North America Prostate Cancer Vaccines Sales Market Share by Country (2018-2029)

    Figure 22. North America Prostate Cancer Vaccines Revenue Market Share by Country (2018-2029)

    Figure 23. United States Prostate Cancer Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 24. Canada Prostate Cancer Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 25. Europe Prostate Cancer Vaccines Sales Market Share by Country (2018-2029)

    Figure 26. Europe Prostate Cancer Vaccines Revenue Market Share by Country (2018-2029)

    Figure 27. Germany Prostate Cancer Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 28. France Prostate Cancer Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 29. U.K. Prostate Cancer Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 30. Italy Prostate Cancer Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 31. Russia Prostate Cancer Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 32. Asia Pacific Prostate Cancer Vaccines Sales Market Share by Region (2018-2029)

    Figure 33. Asia Pacific Prostate Cancer Vaccines Revenue Market Share by Region (2018-2029)

    Figure 34. China Prostate Cancer Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 35. Japan Prostate Cancer Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 36. South Korea Prostate Cancer Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 37. India Prostate Cancer Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 38. Australia Prostate Cancer Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 39. China Taiwan Prostate Cancer Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 40. Indonesia Prostate Cancer Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 41. Thailand Prostate Cancer Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 42. Malaysia Prostate Cancer Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 43. Latin America Prostate Cancer Vaccines Sales Market Share by Country (2018-2029)

    Figure 44. Latin America Prostate Cancer Vaccines Revenue Market Share by Country (2018-2029)

    Figure 45. Mexico Prostate Cancer Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 46. Brazil Prostate Cancer Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 47. Argentina Prostate Cancer Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 48. Middle East & Africa Prostate Cancer Vaccines Sales Market Share by Country (2018-2029)

    Figure 49. Middle East & Africa Prostate Cancer Vaccines Revenue Market Share by Country (2018-2029)

    Figure 50. Turkey Prostate Cancer Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 51. Saudi Arabia Prostate Cancer Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 52. UAE Prostate Cancer Vaccines Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 53. Global Sales Market Share of Prostate Cancer Vaccines by Type (2018-2029)

    Figure 54. Global Revenue Market Share of Prostate Cancer Vaccines by Type (2018-2029)

    Figure 55. Global Prostate Cancer Vaccines Price (US$/Unit) by Type (2018-2029)

    Figure 56. Global Sales Market Share of Prostate Cancer Vaccines by Application (2018-2029)

    Figure 57. Global Revenue Market Share of Prostate Cancer Vaccines by Application (2018-2029)

    Figure 58. Global Prostate Cancer Vaccines Price (US$/Unit) by Application (2018-2029)

    Figure 59. Prostate Cancer Vaccines Value Chain

    Figure 60. Prostate Cancer Vaccines Production Process

    Figure 61. Channels of Distribution (Direct Vs Distribution)

    Figure 62. Distributors Profiles

    Figure 63. Bottom-up and Top-down Approaches for This Report

    Figure 64. Data Triangulation

    Figure 65. Key Executives Interviewed